{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:03:27Z","timestamp":1790071407977,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jinorgbio.2026.113428","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:05:36Z","timestamp":1786201536000},"page":"113428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis, characterization and molecular docking studies of iridium(III) complex with substituted morpholine for glioblastoma cells"],"prefix":"10.1016","volume":"284","author":[{"given":"Cigdem","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unal","family":"Arabaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsah","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar Obakan","family":"Yerlikaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafet","family":"Kilincarslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2026.113428_bb0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/cancers17010146","article-title":"Glioblastoma: clinical presentation, multidisciplinary management, and long-term outcomes","volume":"17","author":"Sipos","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0010","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/carcin\/bgz032","article-title":"Molecular classification of IDH-mutant glioblastomas based on gene expression profiles","volume":"40","author":"Wu","year":"2019","journal-title":"Carcinogenesis"},{"issue":"10412","key":"10.1016\/j.jinorgbio.2026.113428_bb0015","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","article-title":"Primary brain tumours in adults","volume":"402","author":"van den Bent","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0025","article-title":"A review: PI3K\/AKT\/mTOR signaling pathway and its regulated eukaryotic translation initiation factors may be a potential therapeutic target in esophageal squamous cell carcinoma","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0030","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","article-title":"Recent advances and limitations of mTOR inhibitors in the treatment of cancer","volume":"22","author":"Ali","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0035","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/curroncol31070296","article-title":"Temozolomide (TMZ) in the treatment of glioblastoma Multiforme\u2014a literature review and clinical outcomes","volume":"31","author":"Jezierza\u0144ski","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0040","first-page":"513","article-title":"Temozolomide: an updated overview of resistance mechanisms, nanotechnology advances and clinical applications","volume":"19","author":"Ortiz","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119673","article-title":"MGMT in TMZ-based glioma therapy: multifaceted insights and clinical trial perspectives","volume":"1871","author":"Shaw","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0050","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s11064-011-0701-1","article-title":"Drug resistance in glioblastoma: a mini review","volume":"37","author":"Haar","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/cells14070494","article-title":"Therapeutic targets in glioblastoma: molecular pathways, emerging strategies, and future directions","volume":"14","author":"Tang","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70244","article-title":"Potent multi-target inhibition of cholinesterases and carbonic anhydrases by iridium(III)\u2013phenanthroline derivatives: integrated structure\u2013activity relationship, molecular docking and anticancer cell culture studies","volume":"87","author":"K\u00f6ksal","year":"2026","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2026.113317","article-title":"Mitochondria-targeting iridium(III) complex enhances anticancer activity via PDK inhibition and energy metabolism disruption","volume":"280","author":"Xu","year":"2026","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0070","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1039\/D4QI02472A","article-title":"Anticancer iridium(III) cyclopentadienyl complexes","volume":"12","author":"\u0160tarha","year":"2025","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/cancers15010107","article-title":"Targets, mechanisms and cytotoxicity of half-Sandwich Ir(III) complexes are modulated by structural modifications on the Benzazole ancillary ligand","volume":"15","author":"Acu\u00f1a","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0080","doi-asserted-by":"crossref","first-page":"11556","DOI":"10.1039\/D0DT02064H","article-title":"Adjusting the lipid\u2013water distribution coefficient of iridium(III) complexes to enhance the cellular penetration and treatment efficacy to antagonize cisplatin resistance in cervical cancer","volume":"49","author":"Huang","year":"2020","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.110909","article-title":"Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents","volume":"203","author":"Peng","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0090","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/molecules30040801","article-title":"Cytotoxic organometallic iridium(III) complexes","volume":"30","author":"Kostova","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0095","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10534-021-00307-y","article-title":"New iridium bis-terpyridine complexes: synthesis, characterization, antibiofilm and anticancer potentials","volume":"34","author":"Sahin","year":"2021","journal-title":"BioMetals"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108507","article-title":"Designing novel tridentate iridium(III) complexes comprising functionalized benzothiazole ligands to improve anticancer activity by targeting mitochondria","volume":"161","author":"Zhou","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0105","article-title":"Imidazole and Benzimidazole modified half-Sandwich IridiumIIIN-heterocyclic Carbene complexes: synthesis, anticancer application, and organelle targeting","volume":"8","author":"Liu","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103578","article-title":"Morpholine as ubiquitous pharmacophore in medicinal chemistry: deep insight into the structure-activity relationship (SAR)","volume":"96","author":"Kumari","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0115","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00044-024-03233-z","article-title":"Morpholinated curcuminoids against urinary bladder cancer cells: synthesis and anticancer evaluation","volume":"33","author":"Bakun","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0120","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1021\/ja00334a031","article-title":"Photophysical effects of metal-carbon.sigma. bonds in ortho-metalated complexes of iridium(III) and rhodium(III)","volume":"106","author":"Sprouse","year":"1984","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0125","series-title":"Inorg. Synth.","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/9780470132524.ch16","article-title":"16. (\u03b76-Hexamethylbenzene)Ruthenium Complexes","author":"Bennett","year":"1982"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0130","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.matlet.2004.12.002","article-title":"Synthesis, structure, and field-effect property of 2-(benzimidazol-2-yl) quinoline","volume":"59","author":"Chen","year":"2005","journal-title":"Mater. Lett."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128556","article-title":"Synthesis, thermal, electrochemical and catalytic behavior toward transfer hydrogenation investigations of the half-sandwich RuII complexes with 2-(2\u2032-quinolyl)benzimidazoles","volume":"1220","author":"Erdem","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1021\/jp107077t","article-title":"Influence of the fluid-to-film transition on photophysical properties of MLCT excited states in a polymerizable dimethacrylate fluid","volume":"115","author":"Knight","year":"2011","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107706","article-title":"New cyclometalated iridium(III) complexes bearing substituted 2-(1H-benzimidazol-2-yl)quinoline: synthesis, characterization, electrochemical and anticancer studies","volume":"151","author":"Sahin","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0150","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1002\/adfm.200900723","article-title":"Toward highly efficient solid-state white light-emitting electrochemical cells: blue-green to red emitting cationic iridium complexes with imidazole-type ancillary ligands","volume":"19","author":"He","year":"2009","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/prot.10028","article-title":"Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock","volume":"46","author":"\u00d6sterberg","year":"2002","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0160","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","article-title":"A fast flexible docking method using an incremental construction algorithm","volume":"261","author":"Rarey","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0165","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0170","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016573","article-title":"Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1","volume":"296","author":"Ryan","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0175","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1021\/jm300276x","article-title":"Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors","volume":"55","author":"Ashwell","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0180","doi-asserted-by":"crossref","first-page":"26245","DOI":"10.1073\/pnas.2010264117","article-title":"Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1","volume":"117","author":"Nosol","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0185","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1016\/j.bmcl.2013.05.007","article-title":"Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation","volume":"23","author":"Furet","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0190","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1021\/acs.jmedchem.7b00996","article-title":"Structural basis of wee kinases functionality and inactivation by diverse small molecule inhibitors","volume":"60","author":"Zhu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0195","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nsmb791","article-title":"DNA binding and nucleotide flipping by the human DNA repair protein AGT","volume":"11","author":"Daniels","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0200","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1021\/acs.jmedchem.5b00706","article-title":"Fragment-based drug discovery targeting inhibitor of apoptosis proteins: discovery of a non-alanine Lead series with dual activity against cIAP1 and XIAP","volume":"58","author":"Chessari","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0205","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1038\/s41467-024-51692-0","article-title":"Biostructural, biochemical and biophysical studies of mutant IDH1","volume":"15","author":"McCoy","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20121513","article-title":"Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain","volume":"448","author":"Park","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"mTOR kinase structure, mechanism and regulation","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1021\/ml500394m","article-title":"Distinct binding mode of multikinase inhibitor Lenvatinib revealed by biochemical characterization","volume":"6","author":"Okamoto","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0230","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0235","first-page":"17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0240","first-page":"135","article-title":"Drug designing in discovery studio","volume":"14","author":"Jejurikar","year":"2021","journal-title":"Asian J. Res. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12039-018-1492-6","article-title":"Cyclometallated imidazo-phenanthroline iridium complexes and their anticancer activity","volume":"130","author":"Garg","year":"2018","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0255","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/10601325.2016.1143317","article-title":"Synthesis and optical properties of white phosphorescent carbazole - iridium copolymers","volume":"53","author":"Lin","year":"2016","journal-title":"J. Macromol. Sci. Part A"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0260","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1039\/C9QI00081J","article-title":"Mitochondria-targeting cyclometalated iridium(III) complexes for tumor hypoxic imaging and therapy","volume":"6","author":"Li","year":"2019","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2025.122821","article-title":"Structural isomerism and \u03c0-extension effects in iridium(III) complexes: from green to deep-red emission tuning","volume":"587","author":"Wang","year":"2025","journal-title":"Inorg. Chim. Acta"},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113428_bb0270","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1021\/pr200210w","article-title":"Secretome signature of invasive glioblastoma multiforme","volume":"10","author":"Formolo","year":"2011","journal-title":"J. Proteome Res."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113428_bb0275","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s10571-018-0592-7","article-title":"The Tumorgenicity of glioblastoma cell line U87MG decreased during serial in vitro passage","volume":"38","author":"Zeng","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0280","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1039\/C6SC02901A","article-title":"Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(III) complexes","volume":"8","author":"Cao","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.939570","article-title":"Role of PARP inhibitors in glioblastoma and perceiving challenges as well as strategies for successful clinical development","volume":"13","author":"Bisht","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0290","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by clinical PARP inhibitors","volume":"72","author":"Murai","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0295","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0300","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0305","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2018.01.001","article-title":"Bioblockades join the assault on small G protein signalling","volume":"54","author":"Mott","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106510","article-title":"CRISPR\/Cas9-induced knockout reveals the role of ABCB1 in the response to temozolomide, carmustine and lomustine in glioblastoma multiforme","volume":"185","author":"Radtke","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0315","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.aav7102","article-title":"Structural insight into substrate and inhibitor discrimination by human P-glycoprotein","volume":"363","author":"Alam","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0320","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","article-title":"Epidemiology of brain tumors","volume":"34","author":"McNeill","year":"2016","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0325","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2006.03.029","article-title":"A dual PI3 kinase\/mTOR inhibitor reveals emergent efficacy in glioma","volume":"9","author":"Fan","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jinorgbio.2026.113428_bb0330","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase\u2013AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113428_bb0335","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.cdd.4401160","article-title":"Many cuts to ruin: a comprehensive update of caspase substrates","volume":"10","author":"Fischer","year":"2023","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113428_bb0340","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1139\/o97-043","article-title":"Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death","volume":"75","author":"Duriez","year":"1997","journal-title":"Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113428_bb0345","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1369\/jhc.2008.952044","article-title":"Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma","volume":"57","author":"Bressenot","year":"2009","journal-title":"J. Histochem. Cytochem."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426002187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426002187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:17:30Z","timestamp":1790068650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013426002187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":69,"alternative-id":["S0162013426002187"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113428","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, characterization and molecular docking studies of iridium(III) complex with substituted morpholine for glioblastoma cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113428"}}